GlassScriptPhysician profile
Despina Psillides
NPI 1174758668
$1,891.89
in general payments reported to CMS, 2019-2025
32 companies · $408 in 2025
The $408 reported for 2025 was more than what 75% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $130 · 2021: $378 · 2022: $184 · 2023: $217 · 2024: $417 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $244.68 | 2019-2025 | |
| Amgen INC. | $206.42 | 2019-2025 | Repatha, Otezla, Repatha |
| Novo Nordisk INC | $200.55 | 2020-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $177.99 | 2021-2025 | Mounjaro, Zepbound |
| Lundbeck LLC | $155.68 | 2024-2025 | Rexulti |
| Glaxosmithkline, LLC. | $145.96 | 2021-2025 | Shingrix |
| Janssen Pharmaceuticals, INC | $81.66 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $77.35 | 2020-2025 | Capvaxive, Gardasil 9 |
| Exact Sciences Corporation | $65.55 | 2024-2025 | Cologuard Collection Kit |
| Amneal Pharmaceuticals LLC | $56.00 | 2021 | |
| Amarin Pharma, INC. | $53.96 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $53.25 | 2024-2025 | Zoryve |
| Corcept Therapeutics | $43.85 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $42.92 | 2021-2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $28.08 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.85 | 2024 | Trintellix |
| Azurity Pharmaceuticals, INC. | $18.06 | 2023 | Edarbi |
| Dexcom, INC. | $17.59 | 2023 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $15.86 | 2023 | |
| Pfizer INC. | $15.63 | 2023 | |
| Zealand Pharma US, INC. | $15.22 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.00 | 2020 | |
| Mannkind Corporation | $14.71 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.65 | 2025 | |
| Clarus Therapeutics INC. | $14.44 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.38 | 2023 | Farxiga |
| Almatica Pharma LLC | $14.26 | 2022 | |
| Currax Pharmaceuticals LLC | $14.14 | 2020 | |
| Alexion Pharmaceuticals, INC. | $14.06 | 2021 | |
| Antares Pharma, INC. | $14.04 | 2019 | |
| Allergan, INC. | $13.98 | 2020 | |
| Scilex Pharmaceuticals INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Despina Psillides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.